WEISSLAW LLP: Omega Protein Corp. Acquisition May Not Be in the Best Interests of OME Shareholders

NEW YORK, Oct. 13, 2017 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Omega Protein Corp. ("OME" or the "Company") (NYSE: OME) in connection with the proposed acquisition of the Company by Cooke Inc. ("Cooke").  Under the terms of the acquisition agreement, the Company's shareholders will receive $22.00 in cash for each OME share they own.

WeissLaw is investigating whether OME's Board acted to maximize shareholder value prior to entering into the agreement.  Notably, at least one analyst set a target price of $26.00, or $4.00 above the offer price.  Additionally, shares of OME traded for $26.99, or nearly $5.00 above the offer price, as recently as January of this year. 

Given these facts, WeissLaw is investigating whether OME's Board acted in the best interests of its public shareholders to maximize shareholder value prior to entering into the agreement.  If you own OME shares and would like more information about your rights or our investigation, or if you have information to share with us, please contact Joshua Rubin by telephone at [phone] or by email at [e-mail].  

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at [e-mail] or fill out the form on our website, http://www.weisslawllp.com/omega-protein-corp/

 

View original content:http://www.prnewswire.com/news-releases/weisslaw-llp-omega-protein-corp-acquisition-may-not-be-in-the-best-interests-of-ome-shareholders-300536458.html

SOURCE WeissLaw LLP

Copyright 2017 PR Newswire